Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:MYOV

Myovant Sciences (MYOV) Stock Price, News & Analysis

Myovant Sciences logo

About Myovant Sciences Stock (NYSE:MYOV)

Advanced Chart

Key Stats

Today's Range
$26.98
$27.00
50-Day Range
$26.88
$26.99
52-Week Range
$7.67
$27.06
Volume
2.26 million shs
Average Volume
1.17 million shs
Market Capitalization
$2.62 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MYOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Myovant Sciences and its competitors with MarketBeat's FREE daily newsletter.

MYOV Stock News Headlines

Myovant Sciences Stock Price History
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

MYOV Stock Analysis - Frequently Asked Questions

Myovant Sciences Ltd. (NYSE:MYOV) released its earnings results on Tuesday, October, 26th. The company reported ($0.23) EPS for the quarter, beating the consensus estimate of ($0.34) by $0.11. The business had revenue of $77.90 million for the quarter, compared to analyst estimates of $72.67 million.

Myovant Sciences (MYOV) raised $176 million in an initial public offering on Thursday, October 27th 2016. The company issued 13,000,000 shares at a price of $12.00-$15.00 per share. Citigroup, Cowen and Company, Evercore ISI and Barclays served as the underwriters for the IPO and JMP Securities and Baird were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Myovant Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Pfizer (PFE), Inovio Pharmaceuticals (INO), Tesla (TSLA), Advanced Micro Devices (AMD) and Alibaba Group (BABA).

Company Calendar

Last Earnings
10/26/2021
Today
7/25/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:MYOV
Previous Symbol
NASDAQ:MYOV
CIK
1679082
Fax
N/A
Employees
407
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.91)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$205.98 million
Net Margins
-48.47%
Pretax Margin
-42.81%
Return on Equity
N/A
Return on Assets
-39.36%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.57
Quick Ratio
1.45

Sales & Book Value

Annual Sales
$230.97 million
Price / Sales
11.36
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($5.04) per share
Price / Book
-5.35

Miscellaneous

Outstanding Shares
97,240,000
Free Float
95,388,000
Market Cap
$2.62 billion
Optionable
Not Optionable
Beta
2.17

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:MYOV) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners